Rani Therapeutics Holdings, Inc. (RANI) Free cash flow 2020–2025
Rani Therapeutics Holdings, Inc. (RANI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.8MFY2025 · since FY2020: -$16.2M → -$18.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.8M | +47.4% |
| FY2024 | -$35.8M | +31.8% |
| FY2023 | -$52.5M | -9.0% |
| FY2022 | -$48.1M | -47.0% |
| FY2021 | -$32.8M | -102.7% |
| FY2020 | -$16.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice